We are live on ! Find out more
MDSL

M.D. Sass LLC Portfolio holdings

AUM $1.53B
1-Year Est. Return 30.78%
This Fund
S&P 500
This Quarter Est. Return
+2.12%
1 Year Est. Return
+30.78%
3 Year Est. Return
+80.09%
5 Year Est. Return
+105.45%
10 Year Est. Return
+339.34%
AUM
$424M
AUM Growth
-$8.4M
Cap. Flow
-$9.61M
Cap. Flow %
-2.27%
Top 10 Hldgs %
42.34%
Holding
57
New
3
Increased
16
Reduced
32
Closed
4

Top Buys

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$15.8M
2
NXPI icon
NXP Semiconductors
NXPI
+$13M
3
SONY icon
Sony
SONY
+$12.7M
4
CRL icon
Charles River Laboratories
CRL
+$7.24M
5
AMZN icon
Amazon
AMZN
+$1.77M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.37%
2 Technology 17.07%
3 Communication Services 14.01%
4 Healthcare 11.67%
5 Financials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PKG icon
51
Packaging Corp of America
PKG
$20.7B
$690K 0.16%
6,500
-5,103
-44% -$517K
TPHS
52
DELISTED
Trinity Place Holdings Inc.com
TPHS
$486K 0.11%
121,456
+20,456
+20% +$79K
LEN.B icon
53
Lennar Class B
LEN.B
$19B
$309K 0.07%
7,322
+5,260
+255% +$200K
DLTR icon
54
Dollar Tree
DLTR
$23.3B
-18,400
Closed -$1.98M
TER icon
55
Teradyne
TER
$58.2B
-35,000
Closed -$1.68M
GLIBA
56
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
-235,886
Closed -$14.5M
AAWW
57
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
-7,940
Closed -$354K

Similar funds

M.D. Sass LLC's Q3 2019 Portfolio in Review

As of Q3 2019, M.D. Sass LLC held 57 positions worth $424M, down 1.9% from $432M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

M.D. Sass LLC's Q3 2019 filing shows 3 new, 16 increased, 32 reduced and 4 closed positions. Its largest new stake was Quest Diagnostics: 154,057 shares worth $16.5M. The largest sale was GCI Liberty, Inc. Class A Common Stock (DE), an estimated $14.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 30% a quarter earlier, followed by Technology and Communication Services.

  • M.D. Sass LLC's largest Q3 2019 buy was Quest Diagnostics: 154,057 shares worth $16.5M.
  • M.D. Sass LLC added most to Charles River Laboratories in Q3 2019, an estimated $7.24M increase.
  • M.D. Sass LLC's biggest Q3 2019 reduction was Vulcan Materials, cutting an estimated $10.4M.
  • M.D. Sass LLC fully exited GCI Liberty, Inc. Class A Common Stock (DE) in Q3 2019, selling an estimated $14.5M.
  • M.D. Sass LLC's ten largest holdings make up 42% of its $424M portfolio in Q3 2019.
  • M.D. Sass LLC opened 3 new positions and closed 4 in Q3 2019.
  • M.D. Sass LLC's portfolio value fell 1.9% quarter-over-quarter to $424M.

Based on M.D. Sass LLC's 13F filing for Q3 2019, filed 14 Nov 2019.